PASITHEA THERAPEUTICS CORP KTTA

US Healthcare Pharmaceutical Preparations
$0.55
-3.0%
52w: $0.29 – $1.47

Latest 13F among current holders filed 1 month ago (May 20, 2026)

Price — last 12 months

research preview data
0.290.881.47
Jun 20, 2025 Jul 2, 2026
Institutional holders
21
-4 QoQ
13F value
$9.5M
-42.8% QoQ
Smart-money holders
4
signal tier ≥ 2
New smart buyers
0
Q1 2026

Institutional value by quarter

$10.0M
Q1 2024
$152K
Q2 2024
$50K
Q3 2024
$243K
Q4 2024
$99K
Q1 2025
$217K
Q2 2025
$442K
Q3 2025
$16.6M
Q4 2025
$9.5M
Q1 2026

Number of holders

7
Q1 2024
8
Q2 2024
7
Q3 2024
8
Q4 2024
9
Q1 2025
12
Q2 2025
19
Q3 2025
25
Q4 2025
21
Q1 2026

Who owns KTTA?

Q1 2026 filings
FundTypeSharesValue% of fundChange
JANUS HENDERSON GROUP PLC Diversified mechanical2.1M$1.6M0.0%Held
Vivo Capital, LLC ★3Fundamental concentrated2.1M$1.6M0.1%Held
Squadron Capital Management LLC ★2Fundamental concentrated2.1M$1.6M0.6%Held
ADAGE CAPITAL PARTNERS GP, L.L.C. Other2.1M$1.6M0.0%Held
AMERIPRISE FINANCIAL INC Bank broker1.4M$1.0M0.0%-30.0%
Cable Car Capital, LP ★2Fundamental diversified1.2M$895K0.4%+141.3%
Stonepine Capital Management, LLC ★2Fundamental concentrated831.3K$617K0.5%+202.2%
AdvisorShares Investments LLC Other337.5K$250K0.0%+10.8%
Persistent Asset Partners Ltd Quant stat arb290.6K$216K0.1%Held
GEODE CAPITAL MANAGEMENT, LLC Index provider104.0K$77K0.0%+90.8%
RENAISSANCE TECHNOLOGIES LLC Quant stat arb93.4K$69K0.0%New
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical53.8K$40K0.0%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical43.9K$33K0.0%
XTX Topco Ltd Market maker33.8K$25K0.0%+62.4%
UBS Group AG Bank broker26.1K$19K0.0%+97.2%
TWO SIGMA INVESTMENTS, LP Quant stat arb21.1K$16K0.0%-56.8%
NORTHERN TRUST CORP Index provider19.4K$14K0.0%-31.0%
Hurley Capital, LLC Wealth advisor3.7K$3K0.0%Held
Tower Research Capital LLC (TRC) Market maker1.9K$1K0.0%-37.1%
SBI Securities Co., Ltd. Diversified mechanical1.1K$7800.0%Held
JPMORGAN CHASE & CO Bank broker150$1070.0%Held

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.